Blank ChecksIFRS · EUR

Healthcare AI Acquisition Corp.

Healthcare AI Acquisition Corp. is a special purpose acquisition company (SPAC) formed to complete a merger, share exchange, asset acquisition, or similar business combination with an operating business. It has not yet generated operating revenue and currently earns only interest income on trust-account investments while it searches for a target, with a stated focus implied by its name on healthcare and AI-related opportunities.

Operating profit (EBIT)-0.7m EUR
+42.6 %y/y
Net income0.1m EUR
−98.7 %y/y
Free cash flow-0.4m EUR
−11.2 %y/y

Fiscal year 2024 · change from previous year

Development 2021–2024

-3-2-10m EUR2021: EBIT -2.7 m EUR20212022: EBIT -1.2 m EUR20222023: EBIT -1.2 m EUR20232024: EBIT -0.67 m EUR2024-0.67
RevenueOperating profit (EBIT)

Business

Share of revenue
SPAC formation and capital pool100 %

Public-company shell structure that holds IPO proceeds in trust until a business combination is completed or the company liquidates.

Business combination execution0 %

Transaction structuring, negotiation, and closing of a merger or similar acquisition with a target operating business.

Administrative and sponsor support0 %

Minimal corporate administration and sponsor-provided services during the search period.

Customers

The company does not sell products or services to end customers in the normal operating sense. Its economic counterparties are investors, sponsors, directors, and a future target business that may become the operating company after a business combination. Until a transaction closes, the company’s value proposition is access to public capital and a Nasdaq-listed acquisition vehicle.

Public shareholders

Buy the listed shares and warrants for exposure to a future business combination and potential post-merger upside.

Sponsor and insiders

Provide capital, administrative support, and transaction oversight to complete a business combination.

Target operating company

Would combine with the SPAC to access public markets and capital more quickly than a traditional IPO.

Strategy

The core strategy is to complete an initial business combination before the termination date, or else liquidate. Management is also focused on preserving liquidity through sponsor support or working-capital loans while navigating regulatory, listing, and foreign-investment constraints that could narrow the target pool.

Complete an initial business combinationShort term

The SPAC has no operating business until a transaction closes, so execution is existential.

Maintain liquidity and transaction optionalityShort term

The company needs enough cash to fund search, diligence, and closing costs.

Navigate regulatory and listing constraintsShort term

CFIUS, SEC rules, and Nasdaq compliance can delay or block a deal.

Geography

The company is domiciled in the United States and its securities were listed on Nasdaq, but it has no operating revenue or operating footprint yet. Geography matters mainly through the location of potential targets and regulatory review, including possible CFIUS scrutiny if the eventual transaction involves foreign ownership or sensitive U.S. businesses. The reports also note that certain directors and the business combination counterparty have non-U.S. ties, which can affect deal execution risk.

Risks

The company faces classic SPAC risks: failure to complete a business combination, forced liquidation, and the possibility that warrants expire worthless. It also faces regulatory and market-structure risks from Nasdaq delisting, penny-stock treatment, and potential Investment Company Act issues, while cross-border ownership and CFIUS review could reduce the target pool or delay closing.

Sorted by severity
LowMediumHighLowMediumHighImpact →Likelihood →Failure to complete a business combination before the termination date1Investment Company Act classification2Nasdaq delisting and penny-stock designation3CFIUS and foreign ownership review4
Impact is the risk’s severity and likelihood how probable it is over the next few years, both assessed from the company’s reports. Numbers match the list.
  1. Failure to complete a business combination before the termination dateImpact: CriticalLikelihood: High

    The company has no operating business and must liquidate if it cannot close a transaction in time.

    ExposureOctober 142025 termination date
  2. Investment Company Act classificationImpact: CriticalLikelihood: High

    If deemed an unregistered investment company, the SPAC may be forced to abandon the deal process and liquidate.

    Exposure: Trust assets held in short-term securities

  3. Nasdaq delisting and penny-stock designationImpact: HighLikelihood: High

    Trading suspension and delisting reduce liquidity and can impair the ability to complete a transaction.

    Exposure: Public shareholders and warrant holders

  4. CFIUS and foreign ownership reviewImpact: HighLikelihood: High

    Cross-border directors and counterparties may trigger review, delay, or conditions on a deal.

    Exposure: Potential U.S. target businesses with sensitive operations

Accounting

Judgemental items
Fair value of warrant liability

Changes in warrant valuation can create large non-cash gains or losses unrelated to operations.

Impact: Reported net income can swing materially quarter to quarter

Trust-account interest income

Interest on short-term investments is the main source of income before a business combination.

Impact: Declines as redemptions reduce trust balance

Offering costs and temporary equity

SPAC offering costs are treated differently from normal operating expenses and affect equity presentation.

Impact: Impacts balance sheet classification and early-period results

Going-concern assessment

The company’s ability to continue depends on completing a transaction or obtaining financing.

Impact: Material disclosure and liquidation risk

Publicly listed companies with a comparable business focus.

Last updated: 24/09/2026